AVTX- Avalo Therapeutics, Inc.

Insider activity in AVTX over the last quarter tilts toward selling: insiders offloaded a net 101,317 shares worth roughly $2.0M.

Classified under Biotechnology (Health Care sector), AVTX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Neil Garry Arthur	190.3K	-	-
Other	Boyd Taylor	95.0K	-	-
Other	Doyle Mittie	51.8K	$1.04M	-
CFO	Sullivan Christopher Ryan	39.9K	$651.7K	-
Other	Riley Jennifer	37.0K	$725.6K	-

Buys and sells only

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 11, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	2,049,486	$2.50	$5,127,391.12	-222.4%
Jun 10, 2020	Neil Garry Arthur	Chief Scientific Officer	Buy	1,799	$2.28	$4,098.12	+2.5%
Jun 10, 2020	Sullivan Christopher Ryan	Interim CFO	Buy	2,954	$2.28	$6,729.21	New
Jun 10, 2020	Harrell James Archie Jr	Chief Commercial Officer	Buy	16,391	$2.41	$39,558.70	+141.1%
Jun 9, 2020	Cola Michael F	Chief Executive Officer	Buy	100,000	$2.50	$250,000.00	+132.0%
Apr 15, 2020	Cerecor Inc.	10% Owner	Sell	92,777	$1.55	$144,091.96	-0.9%
Apr 3, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	4,280	$2.16	$9,244.80	+0.5%
Mar 31, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	111,914	$2.37	$265,345.68	+15.6%
Mar 23, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	11,000	$2.50	$27,527.48	+1.6%
Mar 19, 2020	Armistice Capital, LLC56	Director, 10% Owner	Buy	1,981,219	$2.05	$4,058,380.18	-155.2%